DK75177A - Fremgangsmade til fremstilling af prostaglandiner - Google Patents
Fremgangsmade til fremstilling af prostaglandinerInfo
- Publication number
- DK75177A DK75177A DK75177A DK75177A DK75177A DK 75177 A DK75177 A DK 75177A DK 75177 A DK75177 A DK 75177A DK 75177 A DK75177 A DK 75177A DK 75177 A DK75177 A DK 75177A
- Authority
- DK
- Denmark
- Prior art keywords
- prostaglandins
- procedures
- production
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 title 1
- 150000003180 prostaglandins Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH526876 | 1976-04-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK75177A true DK75177A (da) | 1977-10-28 |
Family
ID=4290745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK75177A DK75177A (da) | 1976-04-27 | 1977-02-21 | Fremgangsmade til fremstilling af prostaglandiner |
Country Status (13)
Country | Link |
---|---|
JP (1) | JPS52131600A (ru) |
BE (1) | BE852055A (ru) |
DE (1) | DE2707915A1 (ru) |
DK (1) | DK75177A (ru) |
FI (1) | FI770572A (ru) |
FR (2) | FR2353549A1 (ru) |
GB (1) | GB1577647A (ru) |
IL (1) | IL51561A0 (ru) |
NL (1) | NL7702221A (ru) |
NZ (1) | NZ183462A (ru) |
PT (1) | PT66269B (ru) |
SU (1) | SU741794A3 (ru) |
ZA (1) | ZA771215B (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU196598B (en) * | 1986-04-25 | 1988-12-28 | Richter Gedeon Vegyeszet | Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds |
-
1977
- 1977-02-21 DK DK75177A patent/DK75177A/da unknown
- 1977-02-22 FI FI770572A patent/FI770572A/fi not_active Application Discontinuation
- 1977-02-24 DE DE19772707915 patent/DE2707915A1/de not_active Withdrawn
- 1977-02-25 GB GB7981/77A patent/GB1577647A/en not_active Expired
- 1977-02-28 IL IL51561A patent/IL51561A0/xx unknown
- 1977-02-28 NZ NZ183462A patent/NZ183462A/xx unknown
- 1977-03-01 ZA ZA00771215A patent/ZA771215B/xx unknown
- 1977-03-02 NL NL7702221A patent/NL7702221A/nl not_active Application Discontinuation
- 1977-03-03 PT PT66269A patent/PT66269B/pt unknown
- 1977-03-03 JP JP2225977A patent/JPS52131600A/ja active Pending
- 1977-03-03 BE BE175449A patent/BE852055A/xx unknown
- 1977-03-03 SU SU772457126A patent/SU741794A3/ru active
- 1977-03-03 FR FR7706181A patent/FR2353549A1/fr not_active Withdrawn
- 1977-08-30 FR FR7726295A patent/FR2355837A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
NZ183462A (en) | 1979-10-25 |
DE2707915A1 (de) | 1977-11-17 |
ZA771215B (en) | 1978-10-25 |
SU741794A3 (ru) | 1980-06-15 |
FI770572A (ru) | 1977-10-28 |
IL51561A0 (en) | 1977-04-29 |
BE852055A (fr) | 1977-09-05 |
NL7702221A (nl) | 1977-10-31 |
PT66269A (en) | 1977-04-01 |
GB1577647A (en) | 1980-10-29 |
FR2355837A1 (fr) | 1978-01-20 |
PT66269B (en) | 1978-11-07 |
JPS52131600A (en) | 1977-11-04 |
FR2353549A1 (fr) | 1977-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK492677A (da) | Fremgangsmaade til fremstilling af substituerede benzam9der | |
PL195154A1 (pl) | Sposob wytwarzania eterow zwiazkow hydroksybenzodwuheterocyklicznych | |
DK149062C (da) | Analogifremgangsmaade til fremstilling af cefuroximestere | |
DK147777A (da) | Fremgangsmade til fremstilling af acylchromaner | |
DK354678A (da) | Fremgangsmaade til fremstilling af propenylaminer | |
DK589276A (da) | Fremgangsmade til fremstilling af ensymholdige dyrefodermidler | |
DK190275A (da) | Fremgangsmade til fremstilling af humleolie | |
DK46777A (da) | Fremgangsmade til fremstilling af meta-aryloxybenzaldehyder | |
DK435477A (da) | Fremgangsmaade til fremstilling af funktionaliserede celluloser | |
DK144177A (da) | Fremgangsmade til fremstilling af acylayanider | |
DK273376A (da) | Fremgangsmade til fremstilling af 11-desoxy-16-aryloxy-omega-pentanorprostaglandiner | |
DK446277A (da) | Fremgangsmaade til fremstilling af orthoeddikesyrealkylestere | |
DK476277A (da) | Fremgangsmaade til fremstilling af krydslaminater | |
DK476377A (da) | Fremgangsmaade til fremstilling af krydslaminater | |
DK97877A (da) | Fremgangsmade til fremstilling af urinstofderivater | |
DK575576A (da) | Fremgangsmade til fremstilling af krystallinske former af natrium-cefamandol | |
DK87977A (da) | Fremgangsmade til fremstilling af benzylestere | |
DK65877A (da) | Fremgangsmaade til fremstilling af mikrokapsler | |
DK502077A (da) | Fremgangsmaade til fremstilling af gammapyroner | |
DK73977A (da) | Fremgangsmade til fremstilling af d-homosteroider | |
DK551677A (da) | Fremgangsmaade til fremstilling af prostaglandinanaloge | |
DK379277A (da) | Fremgangsmaade til fremstilling af prostaglandinanaloge | |
DK417477A (da) | Fremgangsmaade til fremstilling af urethaner | |
DK77179A (da) | Fremgangsmaade til fremstilling af androstadiener | |
DK541776A (da) | Fremgangsmade til fremstilling af prostaglandiner |